9258 Wealth Management, LLC - PROTEOSTASIS THERAPEUTICS IN ownership

Quarter-by-quarter ownership
9258 Wealth Management, LLC ownership history of PROTEOSTASIS THERAPEUTICS IN
ValueSharesWeighting
Q3 2020$23,000
-28.1%
23,3650.0%0.01%
-30.8%
Q2 2020$32,000
-3.0%
23,365
-6.9%
0.01%
-13.3%
Q1 2020$33,000
-32.7%
25,095
+16.6%
0.02%
-16.7%
Q4 2019$49,00021,5150.02%
Other shareholders
PROTEOSTASIS THERAPEUTICS IN shareholders Q4 2020
NameSharesValueWeighting ↓
Cormorant Asset Management, LP 3,804,027$17,803,0002.95%
HARBOURVEST PARTNERS LLC 440,627$2,062,0000.89%
NEA Management Company, LLC 3,556,778$16,646,0000.61%
Rock Springs Capital Management LP 450,000$2,106,0000.11%
Bain Capital Public Equity Management, LLC 263,498$1,233,0000.07%
ELEMENT CAPITAL MANAGEMENT LLC 65,973$309,0000.06%
Hillhouse Capital Management 865,923$4,053,0000.06%
SABBY MANAGEMENT, LLC 125,151$586,0000.04%
Marshall Wace North America L.P. 684,124$3,421,0000.02%
FNY Partners Fund LP 20,127$94,0000.02%
View complete list of PROTEOSTASIS THERAPEUTICS IN shareholders